Twenty-eight clinical isolates of Yersinia enterocolitica were investigated for their abilities to produce heat-stable enterotoxin (YST). All 21 invasive strains (serogroup 03 biotype 4) canied the previously described gene for YST (yst), with toxin detectable in culture supernatants from 20 strains. One of seven noninvasive, biotype 1A strains also had enterotoxic activity, despite failure to hybridize with a probe for yst. The toxin produced by this noninvasive (serogroup 06) strain resembled YST in terms of molecular size, heat stability, and solubility in methanol. It differed from YST, however, with respect to regulation of its production by temperature and its mechanism of action, which did not appear to involve cyclic GMP.
Yersinia enterocolitica is a versatile enteric pathogen, responsible for a variety of disorders, including diarrhea and colitis (4) . Of the many serobiogroups of Y enterocolitica that occur in nature, only a few consistently cause disease (3, 4) . Pathogenic strains are characterized by a chromosomally encoded ability to invade cultured mammalian cells and the possession of a virulence plasmid, pYV, that may facilitate bacterial survival within host tissues (2, 3, 8, 12, 22) . Y enterocolitica in invasive serobiogroups produces a heat-stable enterotoxin, known as YST (16) (17) (18) , encoded by the chromosomal yst gene (6, 7) . While the role of YST in disease remains controversial (21, 24) , recent animal studies withyst deletion mutants suggest that the toxin is important in causing Yersinia-associated diarrhea (6) .
During a recent prospective study of yersiniosis in children in Santiago, Chile, we obtained 28 isolates of Y enterocolitica (13) . Twenty-one isolates were in a pathogenic serobiogroup (serogroup 03 biotype 4) and carried standard markers for virulence: 11 isolates were from children with diarrhea, and 10 isolates were from asymptomatic control children (Table 1) . Seven additional strains, all from children with diarrhea, belonged to the nonpathogenic biotype, 1A; all lacked the accepted markers of bacterial virulence and did not invade epithelial cells in vitro (13) . We were interested in seeing whether serogroup 03 biotype 4 strains from symptomatic versus asymptomatic children differed in the presence of the yst gene or gene expression. We were also interested in investigating possible mechanisms by which biotype 1A strains might cause disease. * Corresponding author.
Bacteria for these studies were grown in either Trypticase soy broth (BBL, Cockeysville, Md.) with 0.6% (wt/vol) yeast extract or CY medium (15) , with shaking at temperatures ranging from 4 to 37°C for 24 to 168 h. Bacterial cells were removed by centrifugation and filtration through 0.2-,um-pore-size cellulose acetate filters (Millipore Corp., Bedford, Mass.). Filtrates that had been heated to 60°C for 10 min were examined for the presence of enterotoxin in 3-to 4-day-old BALB/c mice and in a competitive enzyme-linked immunosorbent assay (ELISA) by using monoclonal antibody 2F as described previously (14, 19, 27 (10, 13, 23) .
In view of the apparent uniqueness of the YST produced by Y enterocolitica 937, this toxin (tentatively designated YST-II) was characterized further. Examination of the kinetics of toxin production by Y enterocolitica 937 showed that YST-II was produced at temperatures ranging from 4 to 37°C and that toxin production was optimal at 28°C (Fig. 1) . Size fractionation of the toxin was performed with Immersible-CX (Millipore) and Diaflo (Amicon Corp., Danvers, Mass.) ultrafilters with nominal molecular mass cutoffs of 30, 10 , and 5 kDa. Membrane retentates were washed twice with phosphate buffer (pH 7.4) and reconstituted to their original volumes. These preparations and the corresponding filtrates were assayed in infant mice and Ussing chambers containing rabbit intestine, as described previously (23) . The solubility of YST-II in methanol was determined as described elsewhere (25) .
The results of these investigations showed that YST-II was heat stable (resisted boiling for 10 min) and soluble in methanol and that its chief biological activity resided in a 10-to 30-kDa fraction ( Table 2 ). The antigenic relatedness of YST-II to YST was confirmed by using a polyclonal antiserum raised to a YST-bovine serum albumin conjugate (11) to neutralize the activity of YST-II in Ussing chambers (data not shown).
Ussing chambers were also used to determine whether the electrical response of rabbit intestine to YST-II was mediated by cyclic GMP (cGMP), as is the case with YST (20) . [1] .) The two are also antigenically related, as YST-II was recognized by monoclonal and polyclonal antibodies directed against YST. Despite these similarities, YST-II differed from YST in a number of important respects. These include (i) the failure of Y enterocolitica 937 to hybridize with an oligonucleotide DNA probe derived from theyst gene, (ii) the production of YST-II over a temperature range (4 to 37°C) wider than that of traditional YST, which generally is detectable only in cultures incubated between 20 and 30°C (16, 18) , and (iii) this toxin's mechanism of action, which does not appear to be mediated by cGMP. In this respect, YST-II resembles STh, which is produced by some strains of enterotoxigenic E. coli (9, 28) . Unlike STh, however, YST-II is soluble in methanol and active in infant mice. Because YST-II is the only potential virulence factor identified so far in strain 937, it may be responsible for the evident pathogenicity of this isolate.
